Patents by Inventor Roberto Bilzi

Roberto Bilzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dry powder formulation comprising a phosphodiesterase inhibitor
    Patent number: 9308200
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: April 12, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Francesca Schiaretti, Roberto Bilzi
  • DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
    Publication number: 20150342936
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Application
    Filed: August 7, 2015
    Publication date: December 3, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Francesca Schiaretti, Roberto Bilzi
  • Dry powder formulation comprising a phosphodiesterase inhibitor
    Patent number: 9132121
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: September 15, 2015
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Francesca Schiaretti, Roberto Bilzi
  • Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
    Patent number: 8153104
    Abstract: The invention provides a formulation to be administered as dry powder for inhalation suitable for efficacious delivery of low-dosage strength active ingredients to the low respiratory tract of patient. In particular, the invention provides a formulation comprising microparticles constituted of microparticles of a low-dosage strength active ingredient and microparticles of an excipient wherein the MMD of the microparticles is comprised between 2 and 15 micron, at least 10% of the microparticles has a mass diameter (MD) higher than 0.5 micron, and the process of preparation thereof.
    Type: Grant
    Filed: March 16, 2005
    Date of Patent: April 10, 2012
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Roberto Bilzi, Angela Armanni, Roberto Rastelli, Daniela Cocconi, Rosella Musa
  • DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
    Publication number: 20120031403
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Application
    Filed: August 2, 2011
    Publication date: February 9, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Francesca Schiaretti, Roberto Bilzi
  • Pharmaceutical Formulations For Dry Powder Inhalers Comprising A Low-Dosage Strength Active Ingredient
    Publication number: 20070202053
    Abstract: The invention provides a formulation to be administered as dry powder for inhalation suitable for efficacious delivery of low-dosage strength active ingredients to the low respiratory tract of patient. In particular, the invention provides a formulation comprising microparticles constituted of microparticles of a low-dosage strength active ingredient and microparticles of an excipient wherein the MMD of the microparticles is comprised between 2 and 15 micron, at least 10% of the microparticles has a mass diameter (MD) higher than 0.5 micron, and the process of preparation thereof.
    Type: Application
    Filed: March 16, 2005
    Publication date: August 30, 2007
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Roberto Bilzi, Angela Armanni, Roberto Rastelli, Daniela Cocconi, Rosella Musa
  • Modified carrier particles for use in dry powder inhalers
    Patent number: 7132115
    Abstract: The invention relates to carrier particles for use in pharmaceutical compositions for the pulmonary administration of medicaments by means of dry powder inhalers. In particular, the invention relates to a novel technological process for obtaining a carrier modified so as to improve the efficiency of redispersion of active particles and hence increase the respirable fraction. After the treatment of the invention, the surface of said modified carrier particles can also be coated with a suitable additive so as to further improve the respirable fraction.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: November 7, 2006
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Roberto Bilzi, Paolo Ventura, Paolo Chiesi
  • Modified carrier particles for use in dry powder inhalers
    Publication number: 20040096516
    Abstract: The invention relates to carrier particles for use in pharmaceutical compositions for the pulmonary administration of medicaments by means of dry powder inhalers. In particular, the invention relates to a novel technological process for obtaining a carrier modified so as to improve the efficiency of redispersion of active particles and hence increase the respirable fraction. After the treatment of the invention, the surface of said modified carrier particles can also be coated with a suitable additive so as to further improve the respirable fraction.
    Type: Application
    Filed: July 29, 2003
    Publication date: May 20, 2004
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Roberto Bilzi, Paolo Ventura, Paolo Chiesi
  • Modified carrier particles for use in dry powder inhalers
    Publication number: 20040009127
    Abstract: The invention relates to carrier particles for use in pharmaceutical compositions for the pulmonary administration of medicaments by means of dry powder inhalers. In particular, the invention relates to a novel technological process for obtaining a carrier modified so as to improve the efficiency of redispersion of active particles and hence increase the respirable fraction. After the treatment of the invention, the surface of said modified carrier particles can also be coated with a suitable additive so as to further improve the respirable fraction.
    Type: Application
    Filed: April 28, 2003
    Publication date: January 15, 2004
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Roberto Bilzi, Paolo Ventura, Paolo Chiesi
  • Modified carrier particles for use in dry powder inhalers
    Patent number: 6641844
    Abstract: The invention relates to carrier particles for use in pharmaceutical compositions for the pulmonary administration of medicaments by means of dry powder inhalers. In particular, the invention relates to a novel technological process for obtaining a carrier modified so as to improve the efficiency of redispersion of active particles and hence increase the respirable fraction. After the treatment of the invention, the surface of said modified carrier particles can also be coated with a suitable additive so as to further improve the respirable fraction.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: November 4, 2003
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Roberto Bilzi, Paolo Ventura, Paolo Chiesi